What ichorbio does

ichorbio Ltd is a privately held UK-based biotechnology company headquartered in Wantage, Oxfordshire, specializing in the manufacture and direct-to-customer sale of research-grade antibodies and biosimilars for preclinical research applications. The company operates a comprehensive catalog of 352+ products spanning in vivo antibodies (with low and ultra-low endotoxin specifications), research biosimilars, monoclonal and recombinant antibodies, isotype controls, bispecific antibodies, antibody drug conjugates (ADCs), recombinant proteins, and auxiliary reagents such as D-Luciferin and in vivo buffers. Core technical capabilities include recombinant antibody production to avoid hybridoma drift, IDEXX IMPACT pathogen testing for guaranteed pathogen-free ultra-low endotoxin products, and manufacturing at scales ranging from milligram to gram quantities to support high-throughput and bulk experimental needs.

The company's business model is anchored on a self-serve e-commerce storefront at ichor.bio with multi-currency support (USD, GBP, EUR), a quote-based process for bulk and custom orders, and a minimum order value of £75. Pricing is unit-based across tiers: research biosimilars ($102–$9,364+), in vivo antibodies ($150–$23,460+), and isotype controls ($129–$23,460), with a 5% promotional discount available (code ONLINE5). ichorbio explicitly positions itself as a cost-competitive alternative to Bio X Cell, claiming up to 37% cost savings for industry customers and 36% on ultra-low endotoxin versions, supported by a content marketing strategy that drives comparison-page traffic from researchers facing incumbent price increases.

The customer base is horizontally segmented across academic and university research institutions, biotechnology companies requiring bulk supply, and contract research organizations (CROs). Products are cited in research from global institutions including Hanyang University, Max Planck Institute, University of Queensland, University of Toronto, Nanyang Technological University, and others across Asia, Europe, North America, and Oceania. The company sells exclusively for research use only (RUO), not for therapeutic or diagnostic use, and supports demand generation through educational content, email campaigns, technical datasheets, and direct comparison content targeting researchers considering supplier switches.

Name

ichorbio

Legal name

ichorbio Ltd

Website

https://ichor.bio

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

ichorbio Ltd is a UK-based biotechnology company that manufactures and sells research-grade antibodies, biosimilars, isotype controls, and recombinant proteins through a direct e-commerce platform, serving academic researchers, biotechnology companies, and contract research organizations globally.

Ownership category

akta.pro rank

Product category

Research Antibodies and Biosimilars

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Research antibodies
• In vivo antibodies
• Research biosimilars
• Monoclonal antibodies
• Recombinant proteins

Headquarters

HQ city

Wantage

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Research Antibodies and Biosimilars Sales: One-time sale of research-grade antibodies and biosimilars for preclinical research use. Products sold in various sizes from 1mg to 500mg and 1g quantities. Products are sold for research purposes only, not for therapeutic or diagnostic use.
2. Bulk and Custom Antibody Manufacturing: Scalable bulk supply capabilities for biotechnology companies and contract research organizations requiring gram-scale quantities for process development and manufacturing.
3. Custom Services: Custom monoclonal antibody expression service for specialized research needs beyond catalog offerings.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

ichorbio manufactures and sells research-grade monoclonal antibodies, recombinant antibodies, and antibody biosimilars for preclinical and in vivo research applications. Its catalog spans over 350 products, covering cell-line authentication reagents, tag antibodies, isotype controls, recombinant proteins, bispecific antibodies, ADCs, Fc-silenced antibodies, and ancillary reagents, with bulk (milligram to gram) supply and custom antibody expression services available.

Product overview

ichorbio is a biotechnology company specializing in research-grade antibodies and biosimilars for preclinical and in vitro research applications. The portfolio is organized around several core product lines: In Vivo Antibodies (validated for animal studies with low/ultra-low endotoxin), Research Biosimilars (including unconjugated biosimilars, bispecific antibodies, and ADC conjugates), Monoclonal and Recombinant Antibodies, Isotype Controls in multiple species formats, and Auxiliary Reagents. Key products include the RMP1-14 anti-PD-1 antibody, PD-1/PD-L1 pathway antibodies, and over 300 cited research area products. The company offers bulk quantities from milligram to gram scale, with Fc-silenced variants (LALAPG, D265A) and specialized Research Panels for oncology and other therapeutic areas. Products are for research use only (RUO), not for therapeutic or diagnostic applications.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vivo Antibodies In Vivo Antibodies are research-grade and in vivo-grade antibody reagents (monoclonal and recombinant, including Fc-silenced clones) intended for administration in preclinical animal studies, sold in bulk quantities with low endotoxin and pathogen-testing specifications.
• Research Biosimilars Research Biosimilars are antibody biosimilars replicating approved therapeutic antibody reference products, supplied for preclinical research and in vivo comparator studies rather than clinical use.
• Monoclonal Antibodies Monoclonal Antibodies offered by ichorbio are research-grade mAbs targeting cell-surface and soluble antigens, supplied for in vitro and in vivo research applications.
• Recombinant Antibodies Recombinant Antibodies are engineered, defined-sequence antibody reagents developed through recombinant expression systems for consistent specificity in research applications.
• Recombinant Proteins Recombinant Proteins are expressed protein reagents used to support immunological and biochemical research workflows such as assay development and target studies.
• Tag Antibodies Tag Antibodies are reagents targeting common epitope tags (e.g., His, FLAG, HA, Myc, GST) used to detect tagged recombinant proteins in research assays.
• Auxiliary Reagents Auxiliary Reagents are supporting buffers, diluents, and related reagents used to facilitate antibody-based research workflows and assay preparation.
• Isotype Controls Isotype Controls are non-targeting, species- and isotype-matched antibody reagents used as negative controls in flow cytometry, immunohistochemistry, and in vivo studies.
• Bispecific Antibodies Bispecific Antibodies are dual-binding engineered antibody reagents designed for research applications requiring simultaneous recognition of two targets.
• Antibody-Drug Conjugates (ADCs) Antibody-Drug Conjugates (ADCs) supplied by ichorbio are research-use conjugates combining targeting antibodies with cytotoxic payloads for preclinical ADC research and development.
• Fc-Silenced Antibodies Fc-Silenced Antibodies are engineered antibody reagents in which Fc-receptor and complement-binding functions have been reduced, used in research where effector function would confound interpretation.
• Custom Antibody Expression Service Custom Antibody Expression is a fee-for-service offering that engineers and expresses client-specified recombinant antibodies and proteins for research applications.
• Research Panels Research Panels are curated bundles of related antibody reagents assembled for specific research applications such as immune checkpoint or T-cell phenotyping studies.
• RMP1-14 Anti-Mouse PD-1 Antibody (In Vivo) RMP1-14 is an in vivo-grade rat anti-mouse PD-1 monoclonal antibody clone supplied for preclinical studies involving PD-1 checkpoint blockade.
• Pivekimab Biosimilar The Pivekimab Biosimilar is a research-grade antibody designed as a biosimilar of the Pivekimab reference therapeutic for preclinical comparator studies.
• Bulk Anti-Human CD18 (IB4) Antibody Bulk Anti-Human CD18 (IB4) Antibody is a research-grade monoclonal antibody targeting human CD18, supplied in bulk quantities for preclinical and in vivo studies.
• Idiotype Antibodies Idiotype Antibodies are reagents used to study immunoglobulin clonality, repertoire, and B-cell populations in research contexts.

Quantifiable outcome

• Up to 37% cost savings for industry compared to Bio X Cell equivalent products
• +1 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bio X Cell: Bio X Cell is the most direct competitor to ichorbio, specializing in low-endotoxin in vivo-grade monoclonal antibodies for preclinical research. The two companies compete head-to-head on identical clones (e.g., anti-PD-1), and ichorbio explicitly markets its 37% cost advantage against Bio X Cell pricing.
• InvivoGen: InvivoGen supplies research antibodies, cell lines, and reagents for immunology and cell biology research. It is a direct peer in the in vivo reagent space serving similar academic and biotech customers, with overlap in isotype controls and immune checkpoint antibodies.

Broad incumbents

• Cell Signaling Technology: Cell Signaling Technology is a major established research antibody provider with broad coverage across immunology, oncology, and cell signaling. While CST focuses more on in vitro applications, it is a comparable research reagent supplier with similar catalog breadth and academic customer base.
• Abcam (Danaher): Abcam is one of the largest research antibody suppliers globally, acquired by Danaher. It serves the same academic and biotech customer base as ichorbio with a much broader catalog, though Abcam's primary focus is in vitro applications rather than in vivo-grade reagents.
• BioLegend (part of Revvity): BioLegend is a large research antibody supplier with strong coverage in flow cytometry and immunology reagents. It serves the same academic and biotech customer base with broader catalog and brand recognition, though it does not specialize in in vivo-grade antibodies to the same extent as ichorbio.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established research antibody supplier with an extensive catalog. It competes with ichorbio in monoclonal and recombinant antibody categories, particularly for academic customers, though it has different strengths in application areas.
• Bio-Techne (R&D Systems): Bio-Techne, including R&D Systems, is a leading research reagent supplier offering antibodies, proteins, and assays. It overlaps with ichorbio in recombinant proteins and antibodies, with much broader product portfolio and stronger brand in the academic research market.

Emerging players

• GenScript: GenScript is a global biotech offering research antibody services, recombinant protein production, and biosimilar reagents. It overlaps with ichorbio in recombinant antibody manufacturing and is a competitive supplier in the bulk and custom antibody segment, particularly with biotech customers.
• Sino Biological: Sino Biological is a Chinese-based research reagent supplier offering recombinant antibodies, proteins, and other reagents. It competes with ichorbio on catalog recombinant antibodies and price-sensitive segments, with particular strength in recombinant protein and antibody expression services.
• Proteintech: Proteintech is a research antibody supplier with a strong catalog of polyclonal and monoclonal antibodies. It overlaps with ichorbio in catalog recombinant antibodies and is increasingly competitive in the academic research market with similar pricing positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ichorbio
• Facebookfacebook.com/ichorbio
• LinkedInlinkedin.com/company/ichorbio

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ichorbio